Evaluation of Vitreous Modifications After Cataract Surgery

ConditionsVitreous Detachment Cataract (Post-operative Cataract Surgery Follow-up)

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age50+

SponsorUniversity of Trieste

About this trial

This study aims to evaluate changes in vitreous structure and the vitreoretinal interface following cataract surgery using spectral-domain optical coherence tomography (OCT). Patients undergoing cataract surgery will undergo standardized OCT imaging before and after surgery. Preoperative and postoperative images will be compared to identify and characterize qualitative and quantitative changes in vitreous morphology, with particular attention to the posterior vitreous and its relationship with the retinal surface.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Presence of cataract scheduled for surgery

Adequate image acquisition quality

Absence of posterior vitreous detachment (PVD)

Availability of both preoperative and postoperative OCT imaging

Disqualifiers

Advanced cataract significantly compromising image quality

Presence of posterior vitreous detachment (PVD)

History of vitreous hemorrhage

Previous vitreoretinal surgery

Trial population

Patients scheduled for cataract surgery without posterior vitreous detachment

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

cataract surgery
Procedure/Surgery
standard cataracte surgery

Treatment groups

15 Participants

are divided into 1 treatment group

Group A: No vitreous detachment1 intervention

Trial outcomes

Primary outcomes

Number of Participants With Postoperative Changes in Vitreous Morphology or Vitreoretinal Interface Configuration

Preoperative and postoperative OCT images will be compared to identify participants showing structural changes in the posterior vitreous or vitreoretinal interface, including changes in posterior hyaloid position, vitreoretinal attachment status, and the development of partial or complete posterior vitreous detachment (PVD). Results will be reported as the number and proportion of participants presenting these postoperative changes.

Time frame

4 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Trieste

Lead sponsor

Centre Hospitalier Intercommunal Creteil

Sponsor institution

Source ClinicalTrials.gov

Apply now